Učitavanje...
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...
Spremljeno u:
| Izdano u: | J Fungi (Basel) |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765807/ https://ncbi.nlm.nih.gov/pubmed/33348852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040373 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|